The Anti-Apoptotic Activity of β-Synuclein Mediated via Akt Signaling Is Severely Lost During Prion Infection
Open Access
- 2 March 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (5) , 2344
Abstract
Prion diseases are fatal neurodegenerative disorders characterized by profound neuronal damage. Despite evidence supporting a neuroprotective role for β-synuclein (β-syn) in neurodegeneration, its potential functions and mechanisms in prion disease have not been elucidated. To investigate the role of β-syn, we systematically analyzed its alterations in the central nervous system of several prion-infected rodent models and cell models. A series of biochemical, cellular, and immunofluorescence assays were conducted to explore the relationship between β-syn and protein kinase B (Akt) signaling and between β-syn and prion protein (PrP), and its neuroprotective role in prion disease. Student’s t-test was used for statistics. At the terminal stage of prion disease, β-syn and Akt exhibited a parallel and remarkable decrease in rodent brains, contrasting with the slight but significant increase observed at early to middle stages. Dual-stained immunofluorescence assays confirmed that β-syn is localized within NeuN-positive neurons. Further structural and functional analyses revealed a high-affinity molecular interaction between β-syn and Akt, with the N-terminal region of β-syn being essential for binding to Akt1. In a cell model of PrP aggregation, β-syn overexpression suppressed cytochrome c-induced apoptosis, which was demonstrated by decreased levels of cleaved caspase-3. Notably, this anti-apoptotic effect was partially abolished upon Akt knockdown, indicating a dependence on Akt signaling. Moreover, colocalization of β-syn and PrP was observed in rodent brains. Consistently, in cellular models of prion infection and PrP aggregation, β-syn overexpression not only reduced PrP levels but also ameliorated its aberrant histological distribution. Our findings demonstrate that the anti-apoptotic activity of β-syn, mediated via Akt signaling, is severely lost during prion infection, thereby suggesting a mechanism of intrinsic neuronal vulnerability and revealing a novel therapeutic strategy.Keywords
Funding Information
- National Key Research and Development Program of China (2023YFC2306000)
- SKLID Development Grants (2021SKLID504)
- SKLID Development Grants (2019SKLID401)
- SKLID Development Grants (2019SKLID603)
- SKLID Development Grants (2021SKLID503)
This publication has 39 references indexed in Scilit:
- Early increase of the synaptic blood marker β‐synuclein in asymptomatic autosomal dominant Alzheimer's diseaseAlzheimer's & Dementia, 2025
- High diagnostic performance of plasma and cerebrospinal fluid beta‐synuclein for sporadic Creutzfeldt–Jakob diseaseAnnals of Clinical and Translational Neurology, 2023
- Abnormal Changes of IL3/IL3R and Its Downstream Signaling Pathways in the Prion-Infected Cell Line and in the Brains of Scrapie-Infected RodentsMolecular Neurobiology, 2023
- TREM2 Inhibits Tau Hyperphosphorylation and Neuronal Apoptosis via the PI3K/Akt/GSK-3β Signaling Pathway In vivo and In vitroMolecular Neurobiology, 2023
- Mechanisms of prion-induced toxicityCell and tissue research, 2022
- PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteinsActa Neuropathologica, 2019
- Interactions between the Intrinsically Disordered Proteins β‐Synuclein and α‐SynucleinProteomics, 2018
- Protein misfolding and disease: the case of prion disordersCellular and Molecular Life Sciences, 2003
- Prion-Induced Neuronal Damage — The Mechanisms of Neuronal Destruction in the Subacute Spongiform Encephalopathies2001
- Neuroaxonal pathology in Creutzfeldt-Jakob diseaseActa Neuropathologica, 1999